Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 562,345 Shares
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) CEO Eric P. Lefkofsky sold 562,345 shares of Tempus AI stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $50.93, for a total value of $28,640,230.85. Following the transaction, the chief executive officer now directly owns 9,457,283 [...]
Tempus AI, Inc. ( NASDAQ:TEM – Get Free Report ) CEO Eric P. Lefkofsky sold 562,345 shares of Tempus AI stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $50.93, for a total value of $28,640,230.85. Following the transaction, the chief executive officer now directly owns 9,457,283 shares in the company, valued at approximately $481,659,423.19. The trade was a 5.61 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link . Tempus AI Stock Performance Shares of NASDAQ TEM opened at $49.10 on Friday. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The business’s fifty day moving average price is $54.30 and its 200-day moving average price is $52.44. Institutional Inflows and Outflows Institutional investors have recently made changes to their positions in the company. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI during the 3rd quarter valued at $30,000. Operose Advisors LLC purchased a new position in shares of Tempus AI during the 4th quarter valued at $25,000. Farther Finance Advisors LLC bought a new stake in shares of Tempus AI during the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC raised its stake in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares during the period. Finally, NewEdge Advisors LLC bought a new stake in shares of Tempus AI during the 4th quarter valued at $49,000. Hedge funds and other institutional investors own 24.22% of the company’s stock. Analyst Upgrades and Downgrades Get Our Latest Stock Report on TEM Tempus AI Company Profile ( Get Free Report ) Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. See Also Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter .